-
Fund Dashboard
- Holdings
Biotechnology
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
HSBC SECURITIES USA INC | 4.51 mm | 4.51 mm principal | 4.49 | Repurchase agreement | Long | USA |
SOCIETE GENERALE | 3.90 mm | 3.90 mm principal | 3.88 | Repurchase agreement | Long | USA |
NATWEST MARKETS PLC | 3.47 mm | 3.47 mm principal | 3.45 | Repurchase agreement | Long | USA |
UMB FINANCIAL CORP | 2.66 mm | 2.66 mm principal | 2.64 | Repurchase agreement | Long | USA |
INCY Incyte Corporation | 2.47 mm | 33.33 k shares | 2.46 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 2.34 mm | 6.25 k shares | 2.32 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 2.33 mm | 2.33 mm shares | 2.32 | Short-term investment vehicle | N/A | USA |
VKTX Viking Therapeutics, Inc. | 2.30 mm | 31.75 k shares | 2.29 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 2.27 mm | 25.58 k shares | 2.26 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 2.23 mm | 32.32 k shares | 2.22 | Common equity | Long | USA |
ABBV AbbVie Inc. | 2.22 mm | 10.91 k shares | 2.21 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY | 2.17 mm | 2.17 mm principal | 2.16 | Repurchase agreement | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 2.14 mm | 16.99 k shares | 2.13 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 2.13 mm | 7.99 k shares | 2.12 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 2.08 mm | 17.33 k shares | 2.07 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 2.08 mm | 4.37 k shares | 2.07 | Common equity | Long | USA |
AMGN Amgen Inc. | 2.04 mm | 6.37 k shares | 2.03 | Common equity | Long | USA |
NTRA Natera, Inc. | 2.03 mm | 16.75 k shares | 2.02 | Common equity | Long | USA |
INSM Insmed Incorporated | 1.91 mm | 28.37 k shares | 1.90 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.88 mm | 10.83 k shares | 1.87 | Common equity | Long | USA |
ROYAL BANK OF CANADA | 1.73 mm | 1.73 mm principal | 1.73 | Repurchase agreement | Long | USA |
MRNA Moderna, Inc. | 1.69 mm | 31.03 k shares | 1.68 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 1.64 mm | 24.95 k shares | 1.64 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 1.54 mm | 1.84 k shares | 1.53 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 1.45 mm | 5.58 k shares | 1.44 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 1.37 mm | 26.79 k shares | 1.36 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.28 mm | 14.64 k shares | 1.27 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 1.24 mm | 26.79 k shares | 1.24 | Common equity | Long | Switzerland |
HALO Halozyme Therapeutics, Inc. | 1.17 mm | 23.22 k shares | 1.17 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 1.12 mm | 21.00 k shares | 1.12 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 1.07 mm | 42.60 k shares | 1.06 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 1.05 mm | 24.94 k shares | 1.05 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 989.46 k | 5.74 k shares | 0.98 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 954.61 k | 24.87 k shares | 0.95 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 948.49 k | 82.12 k shares | 0.94 | Common equity | Long | Bermuda |
EXEL Exelixis, Inc. | 918.74 k | 27.67 k shares | 0.91 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 858.14 k | 8.07 k shares | 0.85 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 856.32 k | 17.21 k shares | 0.85 | Common equity | Long | Virgin Islands (British) |
IOVA Iovance Biotherapeutics, Inc. | 852.83 k | 81.69 k shares | 0.85 | Common equity | Long | USA |
Alkermes Plc | 821.37 k | 31.96 k shares | 0.82 | Common equity | Long | Ireland |
ADMA ADMA Biologics, Inc. | 797.72 k | 48.91 k shares | 0.79 | Common equity | Long | USA |
GERN Geron Corporation | 732.20 k | 178.15 k shares | 0.73 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 712.65 k | 30.44 k shares | 0.71 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 702.39 k | 17.40 k shares | 0.70 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 696.22 k | 25.54 k shares | 0.69 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 682.26 k | 12.19 k shares | 0.68 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 627.74 k | 12.31 k shares | 0.62 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 595.61 k | 20.64 k shares | 0.59 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 587.70 k | 6.97 k shares | 0.58 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 581.87 k | 50.95 k shares | 0.58 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 557.70 k | 19.06 k shares | 0.55 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 534.32 k | 84.54 k shares | 0.53 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 521.56 k | 35.75 k shares | 0.52 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 520.56 k | 17.28 k shares | 0.52 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 515.47 k | 11.25 k shares | 0.51 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 512.83 k | 23.41 k shares | 0.51 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 505.71 k | 12.67 k shares | 0.50 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 497.48 k | 11.20 k shares | 0.50 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 474.39 k | 5.36 k shares | 0.47 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 454.61 k | 31.97 k shares | 0.45 | Common equity | Long | USA |
NVAX Novavax, Inc. | 451.38 k | 46.97 k shares | 0.45 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 443.78 k | 15.77 k shares | 0.44 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 443.74 k | 8.22 k shares | 0.44 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 436.55 k | 74.37 k shares | 0.43 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 428.31 k | 22.27 k shares | 0.43 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 411.53 k | 14.47 k shares | 0.41 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 411.18 k | 10.69 k shares | 0.41 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 404.70 k | 21.46 k shares | 0.40 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 398.79 k | 9.88 k shares | 0.40 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 390.10 k | 7.09 k shares | 0.39 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 388.93 k | 32.82 k shares | 0.39 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 385.56 k | 8.08 k shares | 0.38 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 382.18 k | 14.72 k shares | 0.38 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 381.70 k | 11.31 k shares | 0.38 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 378.04 k | 8.19 k shares | 0.38 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 371.81 k | 46.42 k shares | 0.37 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 355.23 k | 6.83 k shares | 0.35 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 349.37 k | 9.83 k shares | 0.35 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 348.72 k | 11.31 k shares | 0.35 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 334.06 k | 15.32 k shares | 0.33 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 309.57 k | 4.42 k shares | 0.31 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 303.44 k | 13.82 k shares | 0.30 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 298.50 k | 5.14 k shares | 0.30 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 297.03 k | 57.01 k shares | 0.30 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 296.67 k | 11.38 k shares | 0.30 | Common equity | Long | USA |
VCEL Vericel Corporation | 295.95 k | 6.72 k shares | 0.29 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 287.81 k | 11.71 k shares | 0.29 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 287.78 k | 34.63 k shares | 0.29 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 287.27 k | 8.83 k shares | 0.29 | Common equity | Long | USA |
MNKD MannKind Corporation | 278.23 k | 39.35 k shares | 0.28 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 268.13 k | 16.10 k shares | 0.27 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 251.89 k | 13.55 k shares | 0.25 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 251.24 k | 17.07 k shares | 0.25 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 244.60 k | 11.34 k shares | 0.24 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 223.08 k | 14.35 k shares | 0.22 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 205.90 k | 4.59 k shares | 0.20 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 200.92 k | 11.48 k shares | 0.20 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 196.01 k | 49.62 k shares | 0.20 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 191.90 k | 11.48 k shares | 0.19 | Common equity | Long | USA |
CDNA CareDx, Inc | 188.95 k | 8.54 k shares | 0.19 | Common equity | Long | USA |
APLT Applied Therapeutics, Inc. | 176.13 k | 19.92 k shares | 0.18 | Common equity | Long | USA |
XNCR Xencor, Inc. | 168.94 k | 8.04 k shares | 0.17 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 163.42 k | 14.22 k shares | 0.16 | Common equity | Long | USA |
EBS Emergent BioSolutions Inc. | 163.24 k | 18.02 k shares | 0.16 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 162.90 k | 21.75 k shares | 0.16 | Common equity | Long | USA |
ANNX Annexon, Inc. | 161.93 k | 22.12 k shares | 0.16 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 161.15 k | 10.53 k shares | 0.16 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 156.05 k | 30.90 k shares | 0.16 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 151.23 k | 26.39 k shares | 0.15 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 149.67 k | 10.17 k shares | 0.15 | Common equity | Long | USA |
CATX Perspective Therapeutics, Inc. | 149.42 k | 12.65 k shares | 0.15 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 148.91 k | 12.66 k shares | 0.15 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 144.66 k | 8.16 k shares | 0.14 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 142.59 k | 14.32 k shares | 0.14 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 142.10 k | 40.60 k shares | 0.14 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 132.36 k | 7.79 k shares | 0.13 | Common equity | Long | Ireland |
ALT Altimmune, Inc. | 131.36 k | 19.49 k shares | 0.13 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 130.50 k | 11.32 k shares | 0.13 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 128.00 k | 10.36 k shares | 0.13 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 126.91 k | 22.52 k shares | 0.13 | Common equity | Long | USA |
IMNM Immunome, Inc. | 124.95 k | 10.89 k shares | 0.12 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 123.97 k | 15.93 k shares | 0.12 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 115.61 k | 17.46 k shares | 0.12 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 113.42 k | 18.66 k shares | 0.11 | Common equity | Long | USA |
CELC Celcuity Inc. | 109.72 k | 7.08 k shares | 0.11 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 106.82 k | 3.83 k shares | 0.11 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 104.71 k | 4.84 k shares | 0.10 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 101.31 k | 39.65 k shares | 0.10 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 95.92 k | 18.00 k shares | 0.10 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 95.30 k | 13.91 k shares | 0.09 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 90.87 k | 99.75 k shares | 0.09 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 90.53 k | 11.30 k shares | 0.09 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 82.35 k | 9.59 k shares | 0.08 | Common equity | Long | USA |
SVRA Savara Inc. | 76.45 k | 21.03 k shares | 0.08 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 75.78 k | 8.08 k shares | 0.08 | Common equity | Long | USA |
ERAS Erasca, Inc. | 75.23 k | 29.05 k shares | 0.07 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 74.66 k | 6.68 k shares | 0.07 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 70.00 k | 12.88 k shares | 0.07 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 67.96 k | 4.26 k shares | 0.07 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 67.47 k | 3.46 k shares | 0.07 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 63.66 k | 4.39 k shares | 0.06 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 63.57 k | 26.82 k shares | 0.06 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
UBS SECURITIES LLC
|
62.55 k | 4.53 k other units | 0.06 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
GOLDMAN SACHS GROUP, INC
|
60.86 k | 4.58 k other units | 0.06 | Equity derivative | N/A | USA |
KALV KalVista Pharmaceuticals, Inc. | 56.31 k | 5.48 k shares | 0.06 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 55.32 k | 14.39 k shares | 0.06 | Common equity | Long | Canada |
ITOS iTeos Therapeutics, Inc. | 52.68 k | 6.23 k shares | 0.05 | Common equity | Long | USA |
ALEC Alector, Inc. | 44.78 k | 9.10 k shares | 0.04 | Common equity | Long | USA |
AVBP ArriVent BioPharma, Inc. Common Stock | 35.00 k | 1.19 k shares | 0.03 | Common equity | Long | USA |